Why did The a2 Milk Company (ASX:A2M) recall its infant formula in the United States?

The a2 Milk Company initiated a voluntary recall of three batches of its a2 Platinum USA label infant formula after detecting cereulide, a toxin that can cause gastrointestinal distress.

How many units are affected by the a2 Milk Company (ASX:A2M) recall?

The recall involves approximately 63,078 tins of formula manufactured by Synlait Milk (ASX:SM1). Of these, an estimated 16,428 tins were already sold to consumers through Amazon, Meijer stores, and the company's direct website.

What are the health risks associated with the a2 Platinum USA label recall?

The contaminant, cereulide, typically triggers symptoms like nausea and vomiting within 30 minutes to six hours of ingestion. These symptoms generally self-resolve within 24 hours. As of the recall date, The a2 Milk Company has reported no confirmed incidents of infant illness or harm related to these batches.

Will the recall affect The a2 Milk Company (ASX:A2M) financial results?

Management expects no material impact on financial results, as the affected product accounts for only about 0.1% of the company’s total sales revenue for H1 FY26. The small volume of the recall relative to global operations suggests that the direct fiscal hit is negligible.

Does this recall impact a2 Milk products sold in Australia, New Zealand, or China?

No, the recall is strictly isolated to the USA-labeled product, which uses a different formulation and specific ingredients compared to other regions. The a2 Milk Company confirmed that all a2 Platinum products sold in Australia, New Zealand, South Korea, Vietnam, and China remain unaffected and safe for consumption.

How does this news affect Synlait Milk (ASX:SM1)?

As the manufacturer of the affected batches, Synlait Milk is assisting with the voluntary recall but does not expect a material impact on its own financial results. Synlait maintained that the product was manufactured in compliance with all relevant standards at the time of production.

a2 Milk recalls USA infant formula batches

Written by Jon CuthbertPublished May. 3 2026Last Updated May. 3 2026

The a2 Milk Company (ASX:A2M) has initiated a voluntary recall of three batches of its a2 Platinum USA label infant milk formula following the detection of cereulide in the product.

Manufactured by Synlait Milk (ASX:SM1), the affected batches comprise approximately 63,078 tins, with an estimated 16,428 already sold to consumers across the United States via Amazon, Meijer stores, and the company’s website.

The issue was identified through rigorous additional testing mandated by updated safety guidelines from the New Zealand Ministry for Primary Industries.

While the product was manufactured in compliance with standards at the time, a2MC believes the toxin originated from a specific ingredient.

Despite the recall, the company reports no confirmed incidents of illness or harm. Cereulide exposure typically triggers gastrointestinal distress, such as nausea and vomiting, within thirty minutes to six hours of ingestion, with symptoms generally resolving within a day.

The recall is strictly limited to the USA-labelled product; formulations sold in Australia, New Zealand, China, and other Asian markets remain unaffected and safe for consumption.

Although the recall involves a significant number of tins, it represents only about 0.1% of the company's H1 FY26 sales revenue and is not expected to have a material impact on the financial results for either a2MC or Synlait.